Interferon γ Induction of Pulmonary Emphysema in the Adult Murine Lung

Chronic inflammation containing CD8+ lymphocytes, neutrophils, and macrophages, and pulmonary emphysema coexist in lungs from patients with chronic obstructive pulmonary disease. Although this inflammatory response is believed to cause the remodeling that is seen in these tissues, the mechanism(s) by which inflammation causes emphysema have not been defined. Here we demonstrate that interferon γ (IFN-γ), a prominent product of CD8+ cells, causes emphysema with alveolar enlargement, enhanced lung volumes, enhanced pulmonary compliance, and macrophage- and neutrophil-rich inflammation when inducibly targeted, in a transgenic fashion, to the adult murine lung. Prominent protease and antiprotease alterations were also noted in these mice. They included the induction and activation of matrix metalloproteinase (MMP)-12 and cathepsins B, H, D, S, and L, the elaboration of MMP-9, and the selective inhibition of secretory leukocyte proteinase inhibitor. IFN-γ causes emphysema and alterations in pulmonary protease/antiprotease balance when expressed in pulmonary tissues.

[1]  D. Postma,et al.  Chronic obstructive pulmonary disease. , 2002, Clinical evidence.

[2]  B. Ma,et al.  Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. , 2000, The Journal of clinical investigation.

[3]  M. Reddehase,et al.  Murine Model of Interstitial Cytomegalovirus Pneumonia in Syngeneic Bone Marrow Transplantation: Persistence of Protective Pulmonary CD8-T-Cell Infiltrates after Clearance of Acute Infection , 2000, Journal of Virology.

[4]  R. M. Senior Mechanisms of COPD: conference summary. , 2000, Chest.

[5]  Nagai,et al.  Apoptosis of alveolar macrophages by cigarette smoke , 2000, Chest.

[6]  P. Jeffery,et al.  Comparison of the structural and inflammatory features of COPD and asthma. Giles F. Filley Lecture. , 2000, Chest.

[7]  B. Fischer,et al.  Neutrophil elastase induces MUC5AC messenger RNA expression by an oxidant-dependent mechanism. , 2000, Chest.

[8]  H. Nagaraja,et al.  Increased Susceptibility to Pulmonary Emphysema among HIV-Seropositive Smokers , 2000, Annals of Internal Medicine.

[9]  R. Flavell,et al.  Airway hyperresponsiveness and airway obstruction in transgenic mice. Morphologic correlates in mice overexpressing interleukin (IL)-11 and IL-6 in the lung. , 2000, American journal of respiratory cell and molecular biology.

[10]  R. Mannon,et al.  Enhanced T cell cytokine gene expression in mouse airway obliterative bronchiolitis. , 2000, Transplantation.

[11]  S. Paludan Synergistic action of pro‐inflammatory agents: cellular and molecular aspects , 2000, Journal of leukocyte biology.

[12]  S. Shapiro,et al.  Animal models for chronic obstructive pulmonary disease: age of klotho and marlboro mice. , 2000, American journal of respiratory cell and molecular biology.

[13]  R. Stockley Neutrophils and protease/antiprotease imbalance. , 1999, American journal of respiratory and critical care medicine.

[14]  P. Jeffery Chairman's Summary , 1999 .

[15]  S. Shapiro,et al.  The macrophage in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[16]  M. Cosio,et al.  Chronic obstructive pulmonary disease. Inflammation of small airways and lung parenchyma. , 1999, American journal of respiratory and critical care medicine.

[17]  W. MacNee,et al.  Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[18]  F. Hargreave,et al.  Induced sputum, eosinophilic bronchitis, and chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[19]  B. O'connor,et al.  CD8(+) T cell subsets and chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[20]  R. Homer,et al.  Airway remodeling in asthma. , 1999, The Journal of clinical investigation.

[21]  A. Ray,et al.  Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation. , 1999, The Journal of clinical investigation.

[22]  R. D. du Bois,et al.  Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies. , 1999, The European respiratory journal.

[23]  L. Fabbri,et al.  CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[24]  A. Marchevsky,et al.  Lung allograft dysfunction correlates with gamma-interferon gene expression in bronchoalveolar lavage. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[25]  H. Boushey Glucocorticoid therapy for chronic obstructive pulmonary disease. , 1999, The New England journal of medicine.

[26]  N. Powe,et al.  The relation between funding by the National Institutes of Health and the burden of disease. , 1999, The New England journal of medicine.

[27]  H. Yoon,et al.  Rhinovirus regulation of IL-1 receptor antagonist in vivo and in vitro: a potential mechanism of symptom resolution. , 1999, Journal of immunology.

[28]  D. Hemenway,et al.  Expansion of interferon-gamma-producing lung lymphocytes in mouse silicosis. , 1999, American journal of respiratory cell and molecular biology.

[29]  J. Wang,et al.  Macrophages are a significant source of type 1 cytokines during mycobacterial infection. , 1999, The Journal of clinical investigation.

[30]  R. Homer,et al.  Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. , 1999, The Journal of clinical investigation.

[31]  D. Cohen,et al.  T cell independence of bleomycin‐induced pulmonary fibrosis , 1999, Journal of leukocyte biology.

[32]  Inflammation in Chronic Obstructive Lung Disease. Proceedings of the 14th Transatlantic Airway Conference. January 1999. , 1999, American journal of respiratory and critical care medicine.

[33]  R. Peto,et al.  Tobacco—the growing epidemic , 1999, Nature Medicine.

[34]  A. Sousa,et al.  Immunopathology of the small-airway submucosa in smokers with and without chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[35]  T. Betsuyaku,et al.  Cysteine proteinases and cystatin C in bronchoalveolar lavage fluid from subjects with subclinical emphysema. , 1998, The European respiratory journal.

[36]  Y. Konttinen,et al.  Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[37]  R. Homer,et al.  Induction of Airway Mucus Production By T Helper 2 (Th2) Cells: A Critical Role For Interleukin 4 In Cell Recruitment But Not Mucus Production , 1997, The Journal of experimental medicine.

[38]  R. Flavell,et al.  Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes. , 1997, The Journal of clinical investigation.

[39]  S. Shapiro,et al.  Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.

[40]  A. Minty,et al.  The related cytokines interleukin-13 and interleukin-4 are distinguished by differential production and differential effects on T lymphocytes. , 1997, European cytokine network.

[41]  E. Gelfand,et al.  Interleukin-5 Expression in the Lung Epithelium of Transgenic Mice Leads to Pulmonary Changes Pathognomonic of Asthma , 1997, The Journal of experimental medicine.

[42]  C. O'connor,et al.  Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. , 1997, Thorax.

[43]  T. Kohno,et al.  The cloning and characterization of a murine secretory leukocyte protease inhibitor cDNA. , 1997, Biochemical and biophysical research communications.

[44]  P. Jeffery,et al.  Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. , 1997, American journal of respiratory and critical care medicine.

[45]  H. Chapman,et al.  Emerging roles for cysteine proteases in human biology. , 1997, Annual review of physiology.

[46]  R. Flavell,et al.  Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction. , 1996, The Journal of clinical investigation.

[47]  S. Chandler,et al.  Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. , 1996, Biochemical and biophysical research communications.

[48]  E. Campbell,et al.  Quantum proteolysis resulting from release of single granules by human neutrophils: a novel, nonoxidative mechanism of extracellular proteolytic activity. , 1996, Journal of immunology.

[49]  G. Trinchieri,et al.  Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. , 1996, Journal of immunology.

[50]  J. Whitsett,et al.  Arrested lung morphogenesis in transgenic mice bearing an SP-C-TGF-beta 1 chimeric gene. , 1996, Developmental biology.

[51]  P. Barnes,et al.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. , 1996, American journal of respiratory and critical care medicine.

[52]  M. Cosio,et al.  Alveolar inflammation and its relation to emphysema in smokers. , 1995, American journal of respiratory and critical care medicine.

[53]  K. Murphy,et al.  The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model , 1995, The Journal of experimental medicine.

[54]  A. Churg,et al.  Smoke-induced emphysema in guinea pigs is associated with morphometric evidence of collagen breakdown and repair. , 1995, The American journal of physiology.

[55]  R. Stockley The role of proteinases in the pathogenesis of chronic bronchitis. , 1994, American journal of respiratory and critical care medicine.

[56]  L. Fabbri,et al.  Airway eosinophilia in chronic bronchitis during exacerbations. , 1994, American journal of respiratory and critical care medicine.

[57]  G. Snider,et al.  Pitfalls in antiprotease therapy of emphysema. , 1994, American journal of respiratory and critical care medicine.

[58]  T. Graubert,et al.  Cloning and expression of the cDNA encoding mouse neutrophil gelatinase: demonstration of coordinate secondary granule protein gene expression during terminal neutrophil maturation. , 1993, Blood.

[59]  S. Kira,et al.  Cathepsin L activity is increased in alveolar macrophages and bronchoalveolar lavage fluid of smokers. , 1993, The American review of respiratory disease.

[60]  L. Fabbri,et al.  Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. , 1993, The American review of respiratory disease.

[61]  J. Stolk,et al.  Induction of emphysema and bronchial mucus cell hyperplasia by intratracheal instillation of lipopolysaccharide in the hamster , 1992, The Journal of pathology.

[62]  D. Rich,et al.  Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. , 1992, The Journal of biological chemistry.

[63]  R. Crystal,et al.  Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. , 1991, The Journal of clinical investigation.

[64]  S. Shapiro,et al.  Human 92- and 72-kilodalton type IV collagenases are elastases. , 1991, The Journal of biological chemistry.

[65]  B. Griffith,et al.  Heart-lung transplantation. , 1987, Texas Heart Institute journal.

[66]  A. McMichael,et al.  CELL-MEDIATED CYTOTOXIC RESPONSE TO RESPIRATORY SYNCYTIAL VIRUS IN INFANTS WITH BRONCHIOLITIS , 1987, The Lancet.

[67]  The definition of emphysema. Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop. , 1985, The American review of respiratory disease.

[68]  R. Senior,et al.  Nicotine is chemotactic for neutrophils and enhances neutrophil responsiveness to chemotactic peptides. , 1984, Science.

[69]  A. Fishman Pulmonary Diseases and Disorders , 1980 .

[70]  Millar Ra,et al.  LYONISATION OF THE X CHROMOSOME. , 1963 .